You are here:

NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
5 December 2024
Expected publication date:
TBC